Beyond COVID-19: Risk and regulatory

US: Maintaining enforcement risk vigilance while pursuing pharma opportunities in China

While many of us remain indoors and practice social distancing, business opportunities, especially in the global pharmaceutical market, continue to grow at a rapid pace.

United States | Publication | April 14, 2020

An ounce of prevention: Minimizing US antitrust risk when evaluating labor practices

US: An ounce of prevention: Minimizing antitrust risk when evaluating labor practices

COVID-19 has forced many companies to evaluate, and implement cuts to their workforces, reductions in pay, benefits, and hours, or both.

United States | Publication | April 09, 2020

Cooperation amid COVID-19: Medical supply collaboration won’t face US antitrust scrutiny

US: Cooperation amid COVID-19: Medical supply collaboration won’t face antitrust scrutiny

The US DOJ announced in a business review letter its intent not to challenge an ongoing collaboration between numerous healthcare companies

United States | Publication | April 09, 2020

Global: Credit for compliance: Achieving the benefits of a robust antitrust compliance program

COVID-19 (coronavirus) is naturally the focus of everyone’s attention currently given the unprecedented scale of the crisis.

Global | Publication | April 08, 2020

Fraud prevention: An essential function during the pandemic

The fraud triangle is a well-known tool in understanding fraud. The three sides – opportunity, incentive, and rationalization – offer an explanation to a person’s decision to commit fraud.

Canada | Publication | April 06, 2020

Alberta becomes the first Canadian province to modify environmental reporting rules in the wake of the COVID-19 pandemic

On March 30 and March 31, Alberta’s minister of environment and parks passed a slew of ministerial orders (the Orders) modifying certain industrial environmental reporting requirements in Alberta.

Canada | Publication | April 06, 2020

How behavioral health care rules are evolving for COVID-19

As the COVID-19 crisis deepens, the US medical system is facing significant uncertainty and is at risk of being overwhelmed.

United States | Publication | April 03, 2020

Financial services defender briefings

Significant volume of material published by the UK regulators, the four key headlines.

United Kingdom | Publication | April 02, 2020

Financial services monthly wrap-up: March 2020

March 2020 has seen a number of responses from the Government, regulators, associations and industry generally addressing issues and risks from the outbreak of the coronavirus (COVID-19). This update includes key regulatory responses in the wake of COVID-19 for the funds and financial services sector. Of the notable developments outside COVID-19, on 10 March 2020 the Australian Securities and Investments Commission (ASIC) published its new regulatory guidance on the foreign financial services providers licensing regime.

Australia | Publication | April 02, 2020